| International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). D Hoyer, DE Clarke, JR Fozard, PR Hartig, GR Martin, EJ Mylecharane, ... Pharmacological reviews 46 (2), 157-203, 1994 | 4033 | 1994 |
| Endothelium‐derived relaxing and contracting factors RF Furchgott, PM Vanhoutte The FASEB Journal 3 (9), 2007-2018, 1989 | 2801 | 1989 |
| Flow-induced release of endothelium-derived relaxing factor GM Rubanyi, JC Romero, PM Vanhoutte American Journal of Physiology-Heart and Circulatory Physiology 250 (6 …, 1986 | 2124 | 1986 |
| Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor GM Rubanyi, PM Vanhoutte American Journal of Physiology-Heart and Circulatory Physiology 250 (5 …, 1986 | 1870 | 1986 |
| Endothelial dysfunction in diabetes AS De Vriese, TJ Verbeuren, J Van de Voorde, NH Lameire, ... British journal of pharmacology 130 (5), 963-974, 2000 | 1524 | 2000 |
| Endothelial dysfunction: a multifaceted disorder (the Wiggers Award Lecture) M Félétou, PM Vanhoutte American Journal of Physiology-Heart and Circulatory Physiology 291 (3 …, 2006 | 1177 | 2006 |
| Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. TF Lüscher, PM Vanhoutte Hypertension 8 (4), 344-348, 1986 | 1086 | 1986 |
| Anti-inflammatory actions of steroids: molecular mechanisms PJ Barnes, I Adcock, M Spedding, PM Vanhoutte Trends in pharmacological sciences 14 (12), 436-441, 1993 | 1076 | 1993 |
| EDHF: bringing the concepts together R Busse, G Edwards, M Félétou, I Fleming, PM Vanhoutte, AH Weston Trends in pharmacological sciences 23 (8), 374-380, 2002 | 1074 | 2002 |
| The endothelium: modulator of cardiovascular function TF Luscher, PM Vanhoutte CRC press, 2020 | 1072* | 2020 |
| Endothelium-dependent hyperpolarization of canine coronary smooth muscle. M Feletou, PM Vanhoutte British journal of pharmacology 93 (3), 515, 1988 | 1072 | 1988 |
| Endothelial dysfunction and vascular disease PM Vanhoutte, H Shimokawa, EHC Tang, M Feletou Acta physiologica 196 (2), 193-222, 2009 | 1042 | 2009 |
| Endothelial dysfunction and vascular disease–a 30th anniversary update PM Vanhoutte, H Shimokawa, M Feletou, EHC Tang Acta physiologica 219 (1), 22-96, 2017 | 999 | 2017 |
| Vascular nitric oxide: Beyond eNOS Y Zhao, PM Vanhoutte, SWS Leung Journal of pharmacological sciences 129 (2), 83-94, 2015 | 996 | 2015 |
| Endothelium and control of vascular function. State of the Art lecture. PM Vanhoutte Hypertension 13 (6_pt_2), 658-667, 1989 | 961 | 1989 |
| Endothelium-derived hyperpolarizing factor: where are we now? M Félétou, PM Vanhoutte Arteriosclerosis, thrombosis, and vascular biology 26 (6), 1215-1225, 2006 | 955* | 2006 |
| Modulation of vascular smooth muscle contraction by the endothelium PM Vanhoutte, GM Rubanyi, VM Miller, DS Houston Annual Review of Physiology 48 (1), 307-320, 1986 | 898 | 1986 |
| Endothelial dysfunction: from physiology to therapy JV Mombouli, PM Vanhoutte Journal of molecular and cellular cardiology 31 (1), 61-74, 1999 | 840 | 1999 |
| Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. JG De Mey, PM Vanhoutte Circulation research 51 (4), 439-447, 1982 | 784 | 1982 |
| Endothelial dysfunction the first step toward coronary arteriosclerosis PM Vanhoutte Circulation Journal 73 (4), 595-601, 2009 | 725 | 2009 |
